Protective	JJ
role	NN
of	IN
gambogic	JJ
acid	NN
in	IN
experimental	JJ
pulmonary	JJ
fibrosis	NN
in	FW
vitro	FW
and	CC
in	FW
vivo	FW
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
disorder	NN
with	IN
poor	JJ
prognosis	NN
.	.

The	DT
treatment	NN
options	NNS
for	IN
IPF	NN
are	VBP
very	RB
limited	JJ
.	.

Gambogic	JJ
acid	NN
(	(
GA	NN
)	)
has	VBZ
anticancer	JJ
effect	NN
and	CC
anti-proliferative	JJ
activity	NN
which	WDT
is	VBZ
extracted	VBN
from	IN
a	DT
dried	VBN
yellow	JJ
resin	NN
of	IN
the	DT
Garcinia	NNP
hanburyi	NN
Hook.f	NN
.	.

[	(
Clusiaceae	NN
(	(
Guttiferae	NN
)	)
]	)
in	IN
Southeast	NNP
Asia	NNP
.	.

However	RB
,	,
the	DT
anti-fibrotic	JJ
activities	NNS
of	IN
GA	NN
have	VBP
not	RB
been	VBN
previously	RB
investigated	VBN
.	.

METHODS	NNS
:	:
In	IN
this	DT
study	NN
,	,
the	DT
effects	NNS
of	IN
GA	NN
on	IN
TGF-b1-mediated	JJ
epithelial-mesenchymal	JJ
transition	NN
(	(
EMT	NN
)	)
in	IN
A549	NN
cells	NNS
and	CC
endothelial-mesenchymal	JJ
transition	NN
(	(
EndoMT	NN
)	)
in	IN
human	JJ
pulmonary	JJ
microvascular	JJ
endothelial	JJ
cells	NNS
(	(
HPMECs	NNS
)	)
,	,
on	IN
the	DT
proliferation	NN
of	IN
human	JJ
lung	NN
fibroblasts	NNS
(	(
HLF-1	NN
)	)
were	VBD
investigated	VBN
in	FW
vitro	FW
,	,
and	CC
on	IN
bleomycin	NN
(	(
BLM	NN
)	)
-	:
induced	VBN
pulmonary	JJ
fibrosis	NN
was	VBD
investigated	VBN
in	FW
vivo	FW
.	.

RESULTS	NNS
:	:
In	IN
TGF-b1	NN
stimulated	VBD
A549	NN
cells	NNS
,	,
treatment	NN
with	IN
GA	NN
resulted	VBD
in	IN
a	DT
reduction	NN
of	IN
EMT	NN
with	IN
a	DT
decrease	NN
in	IN
vimentin	NN
and	CC
p-Smad3	NN
and	CC
an	DT
increase	NN
in	IN
E-cadherin	NN
instead	RB
.	.

In	IN
TGF-b1	NN
stimulated	VBD
HPMECs	NNS
,	,
treatment	NN
with	IN
GA	NN
resulted	VBD
in	IN
a	DT
reduction	NN
of	IN
EndoMT	NN
with	IN
a	DT
decrease	NN
in	IN
vimentin	NN
,	,
and	CC
an	DT
increase	NN
in	IN
VE-cadherin	NN
instead	RB
.	.

In	IN
the	DT
hypoxic	JJ
HPMECs	NNS
,	,
treatment	NN
with	IN
GA	NN
reduced	VBD
Vasohibin-2	NN
(	(
VASH-2	NN
)	)
,	,
whereas	IN
increased	VBN
VASH-1	NN
.	.

In	IN
TGF-b1	NN
stimulated	VBD
HLF-1	NN
,	,
treatment	NN
with	IN
GA	NN
reduced	VBD
HLF-1	NN
proliferation	NN
with	IN
a	DT
decrease	NN
in	IN
platelet-derived	JJ
growth	NN
factor	NN
(	(
PDGF	NN
)	)
and	CC
fibroblast	NN
growth	NN
factor	NN
(	(
FGF-2	NN
)	)
expressions	NNS
.	.

In	FW
vivo	FW
,	,
treatment	NN
with	IN
GA	NN
for	IN
2	CD
weeks	NNS
resulted	VBD
in	IN
an	DT
amelioration	NN
of	IN
the	DT
BLM-induced	JJ
pulmonary	JJ
fibrosis	NN
in	IN
rats	NNS
with	IN
a	DT
lower	JJR
VASH-2	NN
.	.

Instead	RB
,	,
it	PRP
was	VBD
observed	VBN
a	DT
higher	JJR
VASH-1	NN
expression	NN
at	IN
early	JJ
stage	NN
of	IN
fibrosis	NN
at	IN
1	CD
mg/kg	NN
,	,
with	IN
reductions	NNS
of	IN
the	DT
pathological	JJ
score	NN
,	,
collagen	NN
deposition	NN
,	,
a-SMA	NN
,	,
PDGF	NN
and	CC
FGF-2	NN
expressions	NNS
at	IN
fibrotic	JJ
stage	NN
at	IN
0.5	CD
mg/kg	NN
and	CC
1	CD
mg/kg	NN
.	.

CONCLUSION	NN
:	:
In	IN
summary	NN
,	,
GA	NN
reversed	VBD
EMT	NNP
and	CC
EndoMT	NNP
,	,
as	RB
well	RB
as	IN
HLF-1	NN
proliferation	NN
in	FW
vitro	FW
and	CC
prevented	VBD
pulmonary	JJ
fibrosis	NN
in	FW
vivo	FW
by	IN
modulating	VBG
VASH-2	NN
/	:
VASH-1	NN
and	CC
suppressing	VBG
the	DT
TGF-b1	NN
/	:
Smad3	NN
pathway	NN
.	.

